BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Loos M, Schetters D, Hoogeland M, Spijker S, de Vries TJ, Pattij T. Prefrontal cortical neuregulin-ErbB modulation of inhibitory control in rats. European Journal of Pharmacology 2016;781:157-63. [DOI: 10.1016/j.ejphar.2016.04.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Skirzewski M, Cronin ME, Murphy R, Fobbs W, Kravitz AV, Buonanno A. ErbB4 Null Mice Display Altered Mesocorticolimbic and Nigrostriatal Dopamine Levels as well as Deficits in Cognitive and Motivational Behaviors. eNeuro 2020;7:ENEURO. [PMID: 32354758 DOI: 10.1523/ENEURO.0395-19.2020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Paterson C, Cumming B, Law AJ. Temporal Dynamics of the Neuregulin-ErbB Network in the Murine Prefrontal Cortex across the Lifespan. Cereb Cortex 2020;30:3325-39. [PMID: 31897479 DOI: 10.1093/cercor/bhz312] [Reference Citation Analysis]
3 Marchisella E, Wijnands R, Koopmans B, Spijker S, Loos M. Constitutive loss and acute pharmacological manipulation of ErbB4 signaling do not affect attention and inhibitory control in mice. Genes Brain Behav 2018;17:56-69. [PMID: 28792672 DOI: 10.1111/gbb.12402] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]